| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 25 Jul 2024 | 9 Jul 2024 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter ended June 30 2024 with limited review thereon by the Statutory Auditors of the Company Outcome of Board Meeting held on July 25, 2024 (As per BSE Announcement Dated on 25/07/2024) | ||
| Board Meeting | 15 May 2024 | 3 May 2024 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2024 inter alia to consider and approve the Audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and year ended March 31 2024 together with the Auditors Reports thereon by the Statutory Auditors of the Company; and recommend dividend if any on the equity shares of the Company for the financial year 2023-24. The Board of Directors at its meeting held on May 15, 2024 recommended final dividend of Rs. 3.50/- per equity share of Re. 1/- each, subject to the approval of the shareholders. Appointment of Chairperson (As Per BSE Announcement Dated on 15/05/2024) | ||
| Board Meeting | 31 Jan 2024 | 12 Jan 2024 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and nine months ended December 31 2023 with limited review thereon by the Statutory Auditors of the Company. Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023 Intimation under Regulation 30 read with Part A of Schedule IIII of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding changes in Directorship of the Company (As Per BSE Announcement Dated on: 31/01/2024) | ||
| Board Meeting | 24 Nov 2023 | 24 Nov 2023 |
| Pursuant to Regulation 30(2) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today, accepted the resignation of Ms. M. R. Deepthi (DIN: 01746698) as Whole Time Director, Director and Employee of the Company with effect from November 24, 2023 | ||
| Board Meeting | 7 Nov 2023 | 30 Oct 2023 |
| Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the Un-audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and half year ended September 30 2023 with limited review thereon by the Statutory Auditors of the Company Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023 (As Per BSE Announcement Dated on 07.11.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
